{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:27:43Z","timestamp":1784309263027,"version":"3.55.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"66_suppl_3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2006,3,28]]},"DOI":"10.1212\/wnl.66.66_suppl_3.s29","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:40:33Z","timestamp":1336920033000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":60,"title":["An overview of oral contraceptives"],"prefix":"10.1212","volume":"66","author":[{"given":"Cheryl A.","family":"Frye","sequence":"first","affiliation":[{"name":"From the Center for Neuroscience Research, University at Albany, State University of New York, Albany, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"The Boston Women\u2019s Health Book Collective. Birth Control. In: Our bodies ourselves. New York: Touchstone 2005:322\u2013380."},{"key":"e_1_3_1_3_2","unstructured":"Wright KL. Advances in hormonal contraception. Network: hormonal contraceptive methods. 2003;22. Available at: http:\/\/www.fhi.org\/en\/RH\/Pubs\/Network\/v22_3\/NW22-3hormonals.htm. Accessed April 13 2005."},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900001528"},{"key":"e_1_3_1_5_2","unstructured":"Bell S Wise L Cooper-Doyle S Norsigian J. Birth control. In: The Boston Women\u2019s Health Book Collective eds. Our bodies ourselves for the new century. New York: Touchstone; 1998:288\u2013340."},{"key":"e_1_3_1_6_2","unstructured":"Estring (estradiol vaginal ring) [package insert]. Kalamazoo MI: Pharmacia & Upjohn Company 2002."},{"key":"e_1_3_1_7_2","unstructured":"NuvaRing (etonogestrel\/ethinyl estradiol vaginal ring) [package insert]. West Orange NJ: Organon Inc. 2001."},{"key":"e_1_3_1_8_2","unstructured":"Ortho Evra (norelgestromin\/ethinyl estradiol transdermal system) [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc. 2003."},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(03)00141-0"},{"key":"e_1_3_1_10_2","unstructured":"Cyclessa [package insert]. West Orange NJ: Organon USA Inc; 2003."},{"key":"e_1_3_1_11_2","unstructured":"Estrostep [package insert]. Rockaway NJ: Warner Chilcott Inc; 2004."},{"key":"e_1_3_1_12_2","unstructured":"Lo\/Ovral [package insert]. Philadelphia PA: Wyeth Laboratories; 2003."},{"key":"e_1_3_1_13_2","unstructured":"Levlen [package insert]. Wayne NJ: Berlex Laboratories Inc; 1996."},{"key":"e_1_3_1_14_2","unstructured":"Levora [package insert]. Morristown NJ: Watson Pharma Inc; 2003."},{"key":"e_1_3_1_15_2","unstructured":"Loestrin [package insert]. Morris Plains NJ: Parke-Davis; 2003."},{"key":"e_1_3_1_16_2","unstructured":"Microgestin [package insert]. Corona CA: Watson Pharma Inc; 2004."},{"key":"e_1_3_1_17_2","unstructured":"Nordette [package insert]. Philadelphia PA: Wyeth Laboratories; 2001."},{"key":"e_1_3_1_18_2","unstructured":"Low-Ogestrel [package insert]. Morristown NJ: Watson Pharma Inc; 2004."},{"key":"e_1_3_1_19_2","unstructured":"Alesse [package insert]. Philadelphia PA: Wyeth Pharmaceuticals Inc; 2004."},{"key":"e_1_3_1_20_2","unstructured":"Brevicon [package insert]. Corona CA: Watson Pharma Inc; 2004."},{"key":"e_1_3_1_21_2","unstructured":"Jenest. Roseland NJ: Organon USA."},{"key":"e_1_3_1_22_2","unstructured":"Levlite [package insert]. Wayne NJ: Berlex Laboratories; 2001."},{"key":"e_1_3_1_23_2","unstructured":"Modicon [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc; 2004."},{"key":"e_1_3_1_24_2","unstructured":"Tri-Levlen [package insert]. Wayne NJ: Berlex Laboratories; 2001."},{"key":"e_1_3_1_25_2","unstructured":"Triphasil [package insert]. Philadelphia PA: Wyeth Laboratories; 2002."},{"key":"e_1_3_1_26_2","unstructured":"Trivora [package insert]. Morristown NJ: Watson Pharmaceuticals Inc; 2004."},{"key":"e_1_3_1_27_2","unstructured":"Necon [package insert]. Corona CA: Watson Pharmaceuticals Inc; 2000."},{"key":"e_1_3_1_28_2","unstructured":"Ortho-Novum [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc; 1998."},{"key":"e_1_3_1_29_2","unstructured":"Tri-Norinyl [package insert]. Corona CA: Watson Pharmaceuticals Inc; 2000."},{"key":"e_1_3_1_30_2","unstructured":"Ortho-Cyclen [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc; 2001."},{"key":"e_1_3_1_31_2","unstructured":"Ortho Tri-Cyclen [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc; 2002."},{"key":"e_1_3_1_32_2","unstructured":"Ovon [package insert]. Rockaway NJ: Warner Chilcott Inc; 2000."},{"key":"e_1_3_1_33_2","unstructured":"Demulen [package insert]. Chicago IL: Pharmacia Corporation; 2003."},{"key":"e_1_3_1_34_2","unstructured":"Desogen [package insert]. West Orange NJ: Organon; 2004."},{"key":"e_1_3_1_35_2","unstructured":"Mircette [package insert]. West Orange NJ: Organon; 2003."},{"key":"e_1_3_1_36_2","unstructured":"Ortho-cept [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc; 1998."},{"key":"e_1_3_1_37_2","unstructured":"Zovia [package insert]. Corona CA: Watson Laboratories Inc; 2003."},{"key":"e_1_3_1_38_2","unstructured":"Norinyl [package insert]. Corona CA; Watson Pharma Inc; 2004."},{"key":"e_1_3_1_39_2","unstructured":"Ogestrel [package insert]. Corona CA: Watson Pharma Inc; 2000."},{"key":"e_1_3_1_40_2","unstructured":"Ovral. Madison NJ: Wyeth."},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(93)90105-G"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(82)90104-4"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-3-200208060-00010"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5245(02)29234-2"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.2307\/1966591"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.2307\/2134636"},{"key":"e_1_3_1_47_2","first-page":"S5","year":"2004","unstructured":"Sulak PJ. Oral contraceptive update: new agents and regimens. J Fam Pract 2004;suppl:S5\u201312.","journal-title":"J Fam Pract"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.2307\/2134658"},{"key":"e_1_3_1_49_2","first-page":"21","volume":"18","year":"1976","unstructured":"Serious adverse effects of oral contraceptives and estrogens. Med Lett Drugs Ther 1976;18:21\u201322.","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6139.721"},{"key":"e_1_3_1_51_2","first-page":"14","year":"1996","unstructured":"Cannold L. The new progestogen \u201cthird generation\u201d oral contraceptive pills: how safe are they? Healthsharing Women December 1995-March 1996:14\u201319.","journal-title":"Healthsharing Women December 1995-March"},{"key":"e_1_3_1_52_2","unstructured":"Oral contraceptives and risk of blood clots. November 14 1995. Available at: http:\/\/www.fda.gov\/bbs\/topics\/answers\/ans00694.html. Accessed June 17 2005."},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00194-9"},{"key":"e_1_3_1_54_2","first-page":"36","volume":"25","year":"1999","unstructured":"Kirkman RJ, Bromham DR, O\u2019Connor TP, Sahota JE. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results. Br J Fam Plann 1999;25:36\u201340.","journal-title":"Br J Fam Plann"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1783\/147118902101196540"},{"key":"e_1_3_1_56_2","first-page":"8","volume":"4","year":"1995","unstructured":"Trussell J, Ellertson C. Efficacy of emergency contraception. Fertil Control Rev 1995;4:8\u201311.","journal-title":"Fertil Control Rev"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(89)90123-6"},{"key":"e_1_3_1_58_2","first-page":"856","volume":"51","year":"2002","unstructured":"Trends in sexual risk behaviors among high school students\u2013United States, 1991\u20132001. MMWR 2002;51:856\u2013859.","journal-title":"MMWR"},{"key":"e_1_3_1_59_2","first-page":"149","volume":"18","year":"2004","unstructured":"Cromwell PF, Daley AM, Risser WL. Contraception for adolescents: part one. J Pediatr Health Care 2004;18:149\u2013152.","journal-title":"J Pediatr Health Care"},{"key":"e_1_3_1_60_2","unstructured":"Sanfilippo J Creatsas G. Pediatric and adolescent gynecology. In: Kubba A Sanfilippo J Hampton N eds. Contraception and office gynecology. London: WB Saunders; 1999:265\u2013281."},{"key":"e_1_3_1_61_2","first-page":"355","volume":"40","year":"1995","unstructured":"Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995;40:355\u2013360.","journal-title":"J Reprod Med"},{"key":"e_1_3_1_62_2","unstructured":"Potter LS. Oral contraceptive compliance and its role in the effectiveness of the method. In: Cramer JA Spilker B eds. Patient compliance in medical practice and clinical trials. New York: Raven Press 1991:195\u2013207."},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.2307\/2135982"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(97)00264-4"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/1054-139X(92)90015-4"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.2307\/2135452"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(94)00009-4"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.92.2.257"},{"key":"e_1_3_1_69_2","unstructured":"Ortho Tri-Cyclen Lo Tablets [package insert]. Raritan NJ: Ortho-McNeil Pharmaceutical Inc. 2002."},{"key":"e_1_3_1_70_2","unstructured":"Seasonale [package insert]. Pomona NY: Duramed Pharmaceuticals Inc. revised 2003."},{"key":"e_1_3_1_71_2","unstructured":"Preven Emergency Contraceptive Pills [package insert]. Pomona NY: Barr Laboratories Inc. 2004. Available at: www.preven.com\/prodinfo\/prescinfo.asp. Accessed April 13 2005."},{"key":"e_1_3_1_72_2","unstructured":"Plan B [package insert]. Pomona NY: Duramed Pharmaceuticals Inc. revised 2004."},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)90076-0"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(00)00095-0"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.66.66_suppl_3.S29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:44:01Z","timestamp":1711532641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.66.66_suppl_3.S29"}},"subtitle":["Mechanism of action and clinical use"],"short-title":[],"issued":{"date-parts":[[2006,3,28]]},"references-count":73,"journal-issue":{"issue":"66_suppl_3","published-print":{"date-parts":[[2006,3,28]]}},"alternative-id":["10.1212\/WNL.66.66_suppl_3.S29"],"URL":"https:\/\/doi.org\/10.1212\/wnl.66.66_suppl_3.s29","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,28]]}}}